Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Italian Stock Exchange  >  DiaSorin SpA    DIA   IT0003492391

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Italian Stock Exchange
04/13/2017 04/18/2017 04/19/2017 04/20/2017 04/21/2017 Date
65.05(c) 64(c) 64.25(c) 66.1(c) 65.6(c) Last
86 790 205 806 67 592 121 496 103 682 Volume
-1.14% -1.61% +0.39% +2.88% -0.76% Change
More quotes
Financials (€)
Sales 2017 643 M
EBIT 2017 199 M
Net income 2017 134 M
Finance 2017 171 M
Yield 2017 1,31%
Sales 2018 686 M
EBIT 2018 214 M
Net income 2018 146 M
Finance 2018 267 M
Yield 2018 1,43%
P/E ratio 2017 26,99
P/E ratio 2018 24,84
EV / Sales2017 5,44x
EV / Sales2018 4,96x
Capitalization 3 670 M
More Financials
Company
DiaSorin SpA engages in the development, production, and marketing of reagent kits for in vitro diagnostics.Its business segments are the geographic locations in which it operates: Italy and the United Kingdom; Europe which comprises Germany, France, Belgium, the Netherlands, Spain, Portugal,... 
More about the company
Surperformance© ratings of DiaSorin SpA
Trading Rating : Investor Rating :
More Ratings
Latest news on DIASORIN SPA
04/13 DIASORIN : Modification to a Previous Presolicitation Notice - DiaSorin Assay Ki..
04/11 DIASORIN : Sources Sought Notice - DiaSorin Assay Kits
04/05 DIASORIN : Reagents and consumables for Liaison analyzers manufactured by Diasor..
03/25 DIASORIN : reagents and consumables for the production of Liaison analyzers Dias..
02/28 DIASORIN : $25,567 Federal Contract Awarded to DiaSorin
02/23 DIASORIN : reagents and consumables for the production of Liaison analyzers Dias..
2016 DIASORIN : Discover Advances in Parathyroid Hormone Testing in DiaSorin Webinar
2016 DIASORIN : Discover the Clinical Significance of 1,25-Dihydroxyvitamin D Testing..
2016 DIASORIN LAUNCHES ITS FIRST MOLECULA : The new simplexa c. difficile direct mole..
2016 DIASORIN : acquisition of DiaSorin and Alere brand materials
More news
Sector news : Diagnostic & Testing Substances
08:48aDJWHAT'S NEWS : Business & Finance -- WSJ
03:01a Becton Dickinson to acquire Bard for $24 billion
04/23DJBECTON DICKINSON AND : to Acquire C.R. Bard for $24 Billion
04/19DJCardinal Swoops In, Strikes Deal -- WSJ
04/18DJCARDINAL HEALTH : $6.1 Billion Deal for Some Medtronic Operations Raises Debt Co..
More sector news : Diagnostic & Testing Substances
Latest Tweets
2016DiaSorin, accordo con Beckman Coulter.
1
2016BRIEF-U.S. HHS awards $2.6 mln to Diasorin group to develop Zika test  
2016Diasorin, downgrade di Morgan Stanley (SoldiOnline.it)  
2016$DGX, $DGX DiaSorin To Acquire Focus Diagnostics' Business From Quest Diagnos..
1
2016DiaSorin buys Quest's diagnostic products business for $300M
1
More tweets
Qtime:3
News from SeekingAlpha
2016 Winner And Losers Among Italian Companies
2016 Diasorin SPA ADR 2016 Q3 - Results - Earnings Call Slides
2016 DiaSorin buys Quest's diagnostic products business for $300M
Advertisement
Chart DIASORIN SPA
Duration : Period :
DiaSorin SpA Technical Analysis Chart | DIA | IT0003492391 | 4-Traders
Full-screen chart
Technical analysis trends DIASORIN SPA
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 10
Average target price 60,5 €
Spread / Average Target -7,9%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Carlo Rosa Chief Executive Officer, Executive Director & GM
Gustavo Denegri Chairman
Piergiorgio Pedron Chief Financial Officer & Senior Corporate VP
Francesco Colotta Chief Medical Officer & Senior Corporate VP
Chen Menachem Even Executive Director & SVP-Commercial Operations
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
DIASORIN SPA16.62%3 936
BIOMERIEUX22.16%7 335
SICHUAN MACCURA BIOTEC..--.--%1 922
SHANGHAI KEHUA BIO-ENG..--.--%1 444
MEDICALSYSTEM BIOTECHN..--.--%1 260
SIEGFRIED HOLDING AG30.05%1 167
More Results